These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8158687)

  • 1. Phase II trial of 13-cis-retinoic acid plus interferon alpha in non-small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.
    Arnold A; Ayoub J; Douglas L; Hoogendoorn P; Skingley L; Gelmon K; Hirsh V; Eisenhauer E
    J Natl Cancer Inst; 1994 Feb; 86(4):306-9. PubMed ID: 8158687
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II study of all-trans-retinoic acid and alpha-interferon in patients with advanced non-small cell lung cancer.
    Athanasiadis I; Kies MS; Miller M; Ganzenko N; Joob A; Marymont M; Rademaker A; Gradishar WJ
    Clin Cancer Res; 1995 Sep; 1(9):973-9. PubMed ID: 9816069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized phase II/III trial of interferon Alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell Carcinoma: the European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951).
    Aass N; De Mulder PH; Mickisch GH; Mulders P; van Oosterom AT; van Poppel H; Fossa SD; de Prijck L; Sylvester RJ
    J Clin Oncol; 2005 Jun; 23(18):4172-8. PubMed ID: 15961764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic adenocarcinoma of the endometrium treated with 13-cis-retinoic acid plus interferon-alpha.
    Kudelka AP; Freedman RS; Edwards CL; Lippman SM; Tornos CS; Krakoff IH; Kavanagh JJ
    Anticancer Drugs; 1993 Jun; 4(3):335-7. PubMed ID: 8358060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 13-cis-retinoic acid plus interferon-alpha 2a in locally advanced squamous cell carcinoma of the cervix.
    Lippman SM; Kavanagh JJ; Paredes-Espinoza M; Delgadillo-Madrueño F; Paredes-Casillas P; Hong WK; Massimini G; Holdener EE; Krakoff IH
    J Natl Cancer Inst; 1993 Mar; 85(6):499-500. PubMed ID: 8445678
    [No Abstract]   [Full Text] [Related]  

  • 6. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
    Recchia F; Sica G; De Filippis S; Rosselli M; Saggio G; Guerriero G; Pompili P; Rea S
    Anticancer Res; 2000; 20(3B):1985-90. PubMed ID: 10928138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to 13-cis-retinoic acid plus interferon alfa-2a in two patients with therapy-refractory advanced renal cell carcinoma.
    Buer J; Probst M; Ganser A; Atzpodien J
    J Clin Oncol; 1995 Oct; 13(10):2679-80. PubMed ID: 7595723
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II study of alpha-interferon and 13-cis-retinoic acid in metastatic melanoma.
    Dhingra K; Papadopoulos N; Lippman S; Lotan R; Legha SS
    Invest New Drugs; 1993 Feb; 11(1):39-43. PubMed ID: 8349434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active cancer therapy combining 13-cis-retinoic acid with interferon-alpha.
    Dmitrovsky E; Bosl GJ
    J Natl Cancer Inst; 1992 Feb; 84(4):218-9. PubMed ID: 1734081
    [No Abstract]   [Full Text] [Related]  

  • 10. 13-cis-retinoic acid and alpha-interferon in advanced squamous cell cancer of the oesophagus.
    Kok TC; van der Gaast A; Splinter TA
    Eur J Cancer; 1997 Jan; 33(1):165-6. PubMed ID: 9071918
    [No Abstract]   [Full Text] [Related]  

  • 11. Alpha interferon-2b, leucovorin, and 5-fluorouracil (ALF) in non-small cell lung cancer.
    Quan WD; Casal R; Rosenfeld M; Walker PR
    Cancer Biother Radiopharm; 1996 Aug; 11(4):229-34. PubMed ID: 10851542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN).
    Atzpodien J; Kirchner H; Rebmann U; Soder M; Gertenbach U; Siebels M; Roigas J; Raschke R; Salm S; Schwindl B; Müller SC; Hauser S; Leiber C; Huland E; Heinzer H; Siemer S; Metzner B; Heynemann H; Fornara P; Reitz M
    Br J Cancer; 2006 Aug; 95(4):463-9. PubMed ID: 16909131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renal carcinoma: effective modulation of low-dose interferon-alpha and interleukin-2 with medroxyprogesterone acetate and 13-cis retinoic acid].
    Caponetti R; Amodio A; Naglieri E; Caponetti T; Crecco M; Lopez M
    Clin Ter; 2000; 151(4):283-6. PubMed ID: 11107678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 13-Cis-retinoic acid plus interferon-alpha 2a in recurrent respiratory papillomatosis.
    Lippman SM; Donovan DT; Frankenthaler RA; Weber RS; Earley CL; Hong WK; Goepfert H
    J Natl Cancer Inst; 1994 Jun; 86(11):859-61. PubMed ID: 8182767
    [No Abstract]   [Full Text] [Related]  

  • 15. 13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix.
    Lippman SM; Kavanagh JJ; Paredes-Espinoza M; Delgadillo-Madrueño F; Paredes-Casillas P; Hong WK; Holdener E; Krakoff IH
    J Natl Cancer Inst; 1992 Feb; 84(4):241-5. PubMed ID: 1734085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma.
    Motzer RJ; Murphy BA; Bacik J; Schwartz LH; Nanus DM; Mariani T; Loehrer P; Wilding G; Fairclough DL; Cella D; Mazumdar M
    J Clin Oncol; 2000 Aug; 18(16):2972-80. PubMed ID: 10944130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of sex on efficacy, adverse events, quality of life, and delivery of treatment in National Cancer Institute of Canada Clinical Trials Group non-small cell lung cancer chemotherapy trials.
    Wheatley-Price P; Le Maître A; Ding K; Leighl N; Hirsh V; Seymour L; Bezjak A; Shepherd FA;
    J Thorac Oncol; 2010 May; 5(5):640-8. PubMed ID: 20354457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of chemotherapy and recombinant interferon-alpha in advanced non-small cell lung cancer.
    Hastürk S; Kurt B; Kocabaş A; Nadirler F; Orüc O
    Cancer Lett; 1997 Jan; 112(1):17-22. PubMed ID: 9029165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elderly patients with advanced non-small-cell lung cancer.
    Belani CP
    Clin Lung Cancer; 2003 Sep; 5(2):76. PubMed ID: 14596687
    [No Abstract]   [Full Text] [Related]  

  • 20. Cis-platin, vindesine, doxorubicin and cyclophosphamide in the treatment of non-small cell bronchogenic carcinoma.
    Athanassiades P; Lagoudis M; Kostis E
    J Chemother; 1989 Jul; 1(4 Suppl):1205-6. PubMed ID: 16312835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.